PITTSBURGH, Sept. 19 – Joseph C. Maroon, M.D., vice chairman of the University of Pittsburgh Medical Center (UPMC) department of neurosurgery, will compete in the Hawaiian Ironman Triathlon to be held Oct. 18, 2003, in Kona, Hawaii. This 140.6-mile world championship event consists of a 2.4-mile ocean swim, a 112-mile bike race through Kona’s lava fields and a 26.2-mile run.

Dr. Maroon, a resident of Sewickley, has participated in numerous marathons over the last 20 years and more than 50 Olympic distance triathlon events. This event will mark his fifth race of Ironman distance – the most recent being the European Ironman Race in 2000, in which Dr. Maroon finished in the top 10 in his age category. He has competed in previous Ironman competitions in Hawaii, Canada, New Zealand and Germany.

Dr. Maroon qualified for the Hawaiian Ironman race by completing the Muncie, Ind., Endurathon Half Ironman Race. His finishing time of six hours and five minutes designates him as an All-American Triathlete by the United States National Triathlon Association, which sanctions all triathlon events in the United States.

In addition to his athletic endeavors, Dr. Maroon is a professor of neurosurgery and a Heindl Scholar in Neuroscience at UPMC. Dr. Maroon has been the team neurosurgeon for the Pittsburgh Steelers since 1981. With his colleagues, neuropsychologists Mark Lovell, Ph.D., and Mickey Collins, Ph.D., he has developed a neurocognitive testing method to evaluate concussions in sports-related injuries. The Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) technique is the first completely automated system that allows athletic trainers to more accurately determine the severity of a concussion and the safety of a player’s return to play after injury. This neurocognitive test is now widely used throughout the National Football League, National Hockey League, National Association of Stock Car Auto Racing (NASCAR) and hundreds of colleges and high schools across the country.

Dr. Maroon’s current research and clinical activity concerns treating diseases and injuries to the brain and spine with an emphasis on minimally invasive treatment procedures. He is the author of eight books and 33 book chapters, 250 scientific papers and is regarded as a leading specialist in his field.

A native of Wheeling, W.Va., Dr. Maroon also maintains an active neurosurgical practice in the Ohio Valley, with offices in Wheeling and St. Clairsville, Ohio.

NOTE TO EDITORS: For photos of Dr. Maroon, please contact Susan Manko, UPMC News Bureau, 412-647-3555.

Joseph C. Maroon, MD was presented the 2002 Health Care Hero Lifetime Achievement Award by the Pittsburgh Business Times. "The Health Care Hero Awards program recognizes outstanding people and organizations that are making significant strides in the local health care field. Each year, a distinguished panel of judges reviews nominations from doctors, nurses, administrators, educators, therapists, researchers and community groups for six separate award categories. Finalists and awardees were honored at a March 7 reception." - Pittsburgh Business Times, March 15, 2002

A national database by Best Doctors Inc., based in Aiken, S.C., of about 30,000 doctors in 41 specialties is featured in an article in Pittsburgh Magazine, March 2002 issue. Of these, 338 are practicing in the Greater Pittsburgh area and Dr. Maroon was listed for Neurosurgery.

This study is a follow-up study to the clinical safety evaluation of Durasis™ dura substitute already successfully completed at Presbyterian University Hospital by Dr. Maroon. This study will enroll 10 to 20 patients requiring a dura patch following brain surgery. We hope to demonstrate the following characteristics of Durasis™. Freedom from:

Our Practice is still able to see AUSHC members that have out-of-network benefits (PPO,POS, & Indemnity Plans). The patient will have a financial obligation.

Our Practice will see HMO patients if the patient agrees to be self pay or obtain out-of network approval from AUSHC (via the patient's PCP)

Tri-State Neurosurgical UPMC and UPMC St. Margarets have agreed to accept AUSHC contracted rates through 9/30/01 to cover patients we are currently caring for.

As of January 1, 2001, the University Center Office of Tri-State Neurosurgical Associates will be moved to Suite 400B located just a few steps from UPMC Presbyterian University Hospital's main elevators on the hospital's 4th floor central corridor. (See map below.)

RESEARCH:

EVALUATION OF DURASIS ™ DURAL SUBSTITUTE AS A DURA MATER SUBSTITUTE Start-up June/00

Following most craniotomy procedures, the underlying dura mater, which is the tough, fibrous membrane covering the brain, requires repair or augmentation. The ideal substitute for this dura mater has yet to be found. Many types of both biologic and non-living tissue have been used. Most have not been adequate due to cost, durability, suturable, non-toxic, non-permeable and minimum elasticity. Also some have been reported to transmit disease. Also some can produce a foreign body reaction.

The Durasis™ Dural substitute, made by Cook Biotech, Inc., is made of acellular, collagenous material derived from porcine small intestine submucosa. In vitro testing have shown this to be an ideal material for repairing/replacing the dura mater. This study is designed to evaluate the safety of the Durasis™ as a dural substitute.

Patients who will require the use of a dural substitute and who meet other inclusion and exclusion criteria may be asked to participate in this study. Please contact 412-647-3604 with any questions.

The Efficacy of Ventricular Catheters impregnated with Minocycline and Rifampin versus Standard Ventricular Catheters in the Reduction of Catheter Infections

This is a new research study of patients who need an external ventricular catheter. Approximately 750 subjects in several hospitals in the United States will be enrolled in the study with 100 to be enrolled at this Presbyterian University Hospital UPMC.

A ventricular catheter is plastic tube put into the ventricle (cavity) of the brain. It may be used to get samples of the (CSF) fluid from the brain, to drain excess CSF, to monitor pressure within the brain, and/or to deliver fluids and medicine. When a ventricular catheter is placed, infection can occur. By coating a ventricular catheter with an antimicrobial (antibiotics) we hope to reduce the chance of infection.

This study involves a new ventricular catheter, made by Cook, Inc., this is coated with a pair of antimicrobials. We will determine if it is better at protecting against infection than an uncoated (no antibiotics) ventricular catheter. The antimicrobials are called minocycline and rifampin. This is a randomized study and the decision as to whether the patient will receive a coated catheter or an uncoated catheter will be made by chance, like the flip of a coin. The patient will have one chance in two (50%) of getting a ventricular catheter coated with minocycline and rifampin.

Human studies of a similar catheter, which is put into a vein, have been done in a large number of patients. These studies show the use of the catheter to be safe and helpful in lowering the rate of infection related to catheter placement. Although this is the first study of this coated ventricular catheter in humans other tests using a similar coated catheter in blood vessels has been done and shown to be safe. The coated ventricular catheter has been approved by the U.S. Food and Drug Administration (FDA) for only this specific study use, and is not approved for general use. Patients who will require the use of a ventricular catheter and who meet other inclusion and exclusion criteria may be asked to participate in this study. Please contact Dr. Maroon at 412-647-3604 with any questions.

Clinical Investigation of the Safety and Efficacy of Pulsed

The purpose of this study is to evaluate the safety and effectiveness of an external bone growth stimulator to promote fusion in patients undergoing anterior cervical discectomy and interbody fusions for degenerative conditions. Some patients will receive a stimulator to wear while others will not. The treatment group will wear the device for four hours/day for three months. Treatment assignment is based upon a computer generated randomization code, which is similar to flipping a coin heads or tails, to assign treatment group. Approximately 324 patients across 10 centers in the United States will be enrolled in this study. Approximately 60 patients will be enrolled as out patients

The bone growth stimulator, made by Orthofix, Inc., is an external device that is worn around the neck. It emits a pulsed electromagnetic field (PEMF). The electromagnetic field is similar to radio waves in the air. They are there, but they cannot be seen, heard or felt. Pulsed electromagnetic fields have been used for almost 20 years to help heal fractures that have not healed on their own, to promote lumbar spinal fusion that has not progressed on its own, and to increase the frequency of fusion rates in patients who are at risk for not attaining fusion. The purpose of this study is to obtain safety and effectiveness data for clearance for the device for use in the cervical spine.

Effectiveness will be measured by the attainment of fusion as determined from x‑rays and by clinical outcome results based on how the patient feels and functions after the fusion surgery. Safety will be assessed by the collection of adverse events for both treatment groups.

After the anterior cervical fusion surgery, the patient will return at 1 month, 2 months, 3 months, 6 months, 12 months and 18 months from the date of surgery. This schedule is the standard postoperative visit used for post-operative visits. X-rays will be taken at each of these visits to determine fusion progression. In addition, questionnaires will be completed assessing your level of pain, functional status, and general health and well-being.

Patients who will require cervical fusion with plate and who meet other inclusion and exclusion criteria may be asked to participate in this study. Please contact Dr. Wecht at 412-647-3604 with any questions.

Comparison of Experience and Clinical Outcomes following Treatment of Degenerative Disc Disease using Synthes Spine, Small Stature CSLP PLATE

This study is designed to collect data about patients undergoing anterior cervical discectomy and fusion and plating. Fifty patients of Drs. El Kadi and Abla at Presbyterian University Hospital UPMC will be enrolled in the study. The information collected is in the form of questionnaires and routine examinations by physical exam and X-rays. This study is designed to evaluate the process and rate of bone fusion, and how the use of a Synthes Spine, small stature CSLP cervical plate helps that process.

Cervical spine decompressive surgery often will require the use of a plate that is placed over the front of the cervical spine after the spine has been decompressed and after the bone fusion has been placed. This operation is generally done on patients with symptoms related to nerve compression caused by a variety of reasons but mostly degenerative. The use of a plate is very common, especially when the operation requires multiple levels of the cervical spine to be fused. The plate acts like an internal brace that holds the spine rigid during the fusion process. The bone fusion process is when bone cells form a solid bone mass and the less spinal movement during this process the better the fusion. Prior to the use of these plates external braces were all that was used to hold the spine. This often allowed for small movement that in some cases allowed for fusion failure.

Drs. El Kadi and Abla are experts in the area of spinal instrumentation and perform this operation often. They will be using the plate made by Synthes Spine, Co., called Small Stature Cervical Spine Locking Plate System (CSLP). This plate is held in place with screws that hold the bone to the plate and cause it to be rigid.

This study will require a pre-operative, post-operative 1, 3, 6, and 12-month visits. There will be questionnaires to determine how well the patient is functioning and how much pain they may have. A routine physical exam and cervical spine X-ray will also be done. These are considered standard of care for this type of operation.

This data will be used to document the outcome of this type of operation and then use it as a base for comparing a new plating system that will be soon introduced by Synthes Spine, Co. Patients who will require cervical fusion with plate and who meet other inclusion and exclusion criteria may be asked to participate in this study. Please contact Dr. El-Kadi at 412-647-3604 with any questions.

This study would evaluate 30 patients with degenerative disk disease, and/or previous failed surgery, recurrent disc herniation, disc collapse, with positive discogram, who have failed conservative therapy and who meet the indications for posterior interbody fusion (PLIF) procedure using VG2™ interbody bone grafts made by DePuy AcroMed, Co.

Interbody grafts for the lumbar spine have generally been constructed out of made man products such as steel and carbon fiber. The use of bone as a graft is relatively new. After these grafts have been placed in the disc space they have been often augmented with posterior spinal instrumentation such as pedicle screws. We have designed this study to use only the interbody grafts VG2™ with a single level fusion, and only augment with posterior instrumentation if more than one level is fused.

This study would investigate the ease of operation including operative time and direct operative costs. We would investigate length of stay, post-operative pain medication consumption, return to work, Activity-Related Pain (ARP), Visual Analog Scale (VAS) and Functional Assessments. We would also track the rate of fusion for 24 months with serial X-rays. Possible complications and re-operations would also be documented. This study will not differ from the required frequency of follow-up visits and X-rays.

We believe that positive results of this study would add to our belief that the future of spinal instrumentation may be towards the less destructive interbody fusion with natural bone products and away from the massive spinal instrumentation constructs currently used. This study would specifically target the economic issues, and post-operative disability, along with durability of the fusion over a two-year period.

Patients who will require posterior interbody fusion and who meet other inclusion and exclusion criteria may be asked to participate in this study. Please contact Dr. El-Kadi at 412-647-3604 with any questions.

2001-2002 Summary Activity Report for Tri-State Neurosurgical Associates – UPMC

Physicians:

Joseph C. Maroon, MD – Clinical Professor and Vice Chairman, Department of Neurosurgery, Presbyterian University Hospital

Adnan A. Abla, MD – Clinical Associate Professor, Department of Neurosurgery, Presbyterian University Hospital

Matt El Kadi, MD, Ph.D. - Clinical Assistant Professor, Department of Neurosurgery, Presbyterian University Hospital

Daniel A. Wecht, MD - Clinical Assistant Professor, Department of Neurosurgery, Presbyterian University Hospital

Physician Assistants:

Jeff Bost PAC - Department of Neurosurgery, Presbyterian University Hospital

Lawrence Marcello PAC - Department of Neurosurgery, Presbyterian University Hospital

Robert Relic PAC - Department of Neurosurgery, Presbyterian University Hospital

Hospital Affiliations:

UPMC Presbyterian University Hospital

UPMC Passavant Hospital

UPMC Shadyside Hospital

UPMC St. Margaret’s Hospital

UPMC McKeesport

Sewickley Hospital

St. Francis Health System

UPMC The Rehabilitation Institute

Wheeling Hospital

Clinical Office Sites:

PUH SUITE 5C

200 LOTHROP ST

PITTSBURGH, PA 15213

WEXFORD CLINIC

Blaymore 1 #202

1606 CARMODY COURT

SEWICKLEY, PA 15143

PUH SUITE A402

200 LOTHROP ST

PITTSBURGH, PA 15213

WHEELING HOSPITAL

10 MEDICAL PARK, SUITE 104

WHEELING, WV 26003

UPMC WEST

1600 CORAOPOLIS HTS. RD SUITE 2F

CORAOPOLIS, PA 15108

SHADYSIDE OFFICE

MEDICAL BLDG SUITE 616

5200 CENTRE AVE

PITTSBURGH, PA

15232

WR CAMERON WELLNESS CENTER

240 Wellness Way

WASHINGTON, PA 15301

HEMITAGE CLINIC

1599 North Hermitage Rd

Hermitage, PA 16148

UPMC ST. MARGARET HOSPITAL

100 MEDICAL ARTS BUILDING SUITE 318

100 DELAFIELD RD

PITTSBURGH, PA 15215

UPMC MCKEESPORT HOSPITAL

PAINTER BUILDING SUITE 1

500 HOSPITAL WAY

MCKEESPORT, PA 15131

EAST OHIO MEDICAL CENTER

PLAZA WEST

106 PLAZA DRIVE

ST. CLAIRSVILLE, OH 43950

REHAB PLUS

TRI-STATE PLAZA

4217 MALL DRIVE

STEUBENVILLE, OHIO 43952

NATRONA HEIGHTS OFFICE

2801 FREEPORT RD.

NATRONA HEIGHTS, PA 15065

New Office – 2002

Western PA- Surgery Center

6001 Stonewood Dr. SUITE 304

Wexford, PA 15090

New Office – 2002

UPMC Monroeville Medical Center

Suite 400

125 Daugherty Dr.

Monroeville, PA 15146

BOOK CHAPTERS

1. Maroon JC, Field M, Lovell M, Collins M, Bost J: The evaluation of athletes with cerebral concussion. Proceedings of the Congress of Neurological Surgeons In Clinical Neurosurgery, Vol. 49, pp 319-322, 2002.

ARTICLES

1. Bejjani GK, Cockerham KP, Kennerdell JS, Maroon JC: Visual field deficit caused by vascular compression from a suprasellar meningioma: a case report. Neurosurgery, Vol. 50 (5), pp 1129-1132, May, 2002.

2. Bejjani GK, Cockerham KC, Kennerdell JS, Rothfus W, Maroon JC: Commentary. Neurosurg. Vol. 30 (5), 1125, May 2002.

3. Koebbe CJ, Maroon JC, Abla AA, El-Kadi H and bost J: Lumbar microdiscectomy: a historical perspective and current technical considerations. Neurosurg. Focus, Vol 13, pp 1-6, August, 2002.

4. Maroon JC: Current concepts in minimally invasive discectomy. Neurosurgery Vol 51 (2), pp S2-1-S2-9, November, 2002

5. Collins MW, Lovell MR, Iverson GL, Cantu RC, Maroon JC, Field M. Cumulative effects of concussion in high school athletes. Neurosurgery. Vol. 51 (5), pp 1175-1179, Nov. 2002.

1. Collins MW, Iverson GL, Lovell MR, McKeag DB, Norwig J, Maroon JC: Preditors of outcome following sports related concussion. Am. J. Sports Med.

2. Collins MW, Field M, Lovell MR, Iverson G, Johnston KM, Maroon JC, Fu F: Headache following sports concussion: to play or not to play? Am. J. Sports Med., 2002

3. Lovell MR, Collins MW, Maroon JC, et al.: Relationship between on field markers of concussion and post injury cognitive dysfunction in athletes. Am. College of Sports Med, 2002.

4. Collins MW, Field M, Lovell MR, Iverson GL, Johnston JK, Maroon JC and Fu FH: Relationship between post concussion headache and neuropsychological test performance in high school athletes. Am. J. of Sports Med., 2002

9/02 Prospective Evaluation of VG2™ Interbody Fusion for Patients with Discogenic Back Pain: Hikmat El Kadi, MD, Ph.D., Joseph C. Maroon, MD, Adnan A. Abla, MD, William Rothfus, MD, Jeff Bost PAC, Larry Marcello PAC, Robert Relic PAC, Dayna Painter, RN Cheryl Gojkovich RN and Amy Kunkle BS,(University of Pittsburgh, Pittsburgh, PA) CNS 2002 Philadelphia

9/02 Revisiting a Rigid Anterior Cervical Plate System with Fixed-angled Screws Matt El Kadi MD. PhD, Joseph Maroon MD, Adnan Abla MD, Jeff Bost PAC, Lawrence Marcello PAC, Robert Relic PAC, Dayna Painter RN, Cheryl Gojkovich RN, University of Pittsburgh, Pittsburgh, PA CNS 2002 Philadelphia

9/02 Evaluation of a New Dural Substitute for Adult Arnold Chiari Malformation Reconstruction: Ghassan K Bejjani, MD, Joseph Maroon, MD (Pittsburgh, PA), Jeff Bost PAC, Kelly Eddy CNRN (Pittsburgh, PA), Theodore Heise, Ph.D. (Bloomington, IN) CNS 2002 Philadelphia

9/02 New Developments in Concussion Management: The Pittsburgh Steelers Protocol, Joseph C. Maroon, M.D., Mark Lovell, Ph.D., Michael Collins, Ph.D., Jeff Bost PAC CNS 2002 Philadelphia

4/02 Long-Segment Plating of the Anterior Cervical Spine: Radiographic and Clinical Outcome, James P. Burke, MD, PhD, ; Adnan A. Abla, MD; Joseph C. Maroon, MD; Robert Relic, PAC; Jeffrey Bost, PAC; Hikmat El Kadi, MD, PhD; Adib Abla, ; Abir Abla, AANS 2002 Chicago

4/02 Advances in Postoperative Management of Lumbosacral Pedicle Screw Fusion Patients, James P. Burke, MD, Ph.D., ; Adnan A. Abla, MD; Joseph C. Maroon, MD; Jeffrey Bost, PAC; Robert Relic, PAC; Hikmat El Kadi, MD, Ph.D.; Adib Abla, ; Abir Abla, AANS 2002 Chicago

4/02 Salvage Pedicle Screws for Post-Laminectomy Spondylolisthesis and Failed Spinal Fusion, James P. Burke, MD, PhD, ; Adnan A. Abla, MD; Joseph C. Maroon, MD; Jeff Bost, PAC; Robert Relic, MD; Hikmat El Kadi, MD, PhD; Adib Abla, ; Abir Abla, AANS 2002 Chicago

“Randomized, Third-Party Blinded, Multicenter, Clinical Trial to Determine the Safety and Effectiveness of OxiplexÒ/SP Gel for the Reduction of Pain and Symptoms Following Lumbar Disc Surgery [Protocol FZ-SP002]” PRINCIPAL INVESTIGATOR: Joseph C. Maroon MD, Sub-PI, Adnan A. Abla, MD, Hikmat El Kadi, MD, PhD.

Abla AA, El Kadi, H, Incidence of Pedicle Screw Failure in the Lumbar Spine, ARGOS Inaugural Meeting, Nemacolin Woodlands, PA, 8/2—8/4/02.

Neuro Nurses Presentation, Presbyterian University Hospital 5G, 11/4/02 "Neuro Assessment".

CHRISTOPHER J. KOEBBE, M.D., JOSEPH C. MAROON, M.D., ADNAN ABLA, M.D., HIKMAT EL-KADI, M.D., AND JEFFERY BOST, PAC. Lumbar microdiscectomy: a historical perspective and current technical considerations Neurosurg Focus 13 (2):Article 3, 2002,

Clinical Research:

“A Study to Evaluate Clinical Outcomes using VG2 Allograft for Cervical Fusion with the PEAK Anterior Cervical Plate System” PRINCIPAL INVESTIGATOR: Adnan A. Abla, MD, Sub-PI Hikmat El Kadi, MD, PhD.

Matt El-Kadi, MD, Ph.D.

Clinical Research:

Presentations and Posters:

12/3/02 Lecture at Passavant Hospital “New Advances in Spinal Surgery" CME Program

8/2—8/4/02. Abla AA, El Kadi, H, Incidence of Pedicle Screw Failure in the Lumbar Spine, ARGOS Inaugural Meeting, Nemacolin Woodlands, PA,

Clinical Associate Professor, Department of Neurosurgery, University of Pittsburgh Medical Center

Chief of the Department of Surgery/Section of Neurosurgery at St. Margaret's Hospital.

2000 American Heart Association Member, Medical Subcommittee for Operation Stroke

Book Chapter

The Evaluation of Athletes with Cerebral Concussion, Maroon, J.C., Field, M., Lovell, M., Collins, M., Bost, J.B., Clinical Neurosurgery, Lippincott Williams & Wilkins.

Articles

9/02 New Developments in Concussion Management: The Pittsburgh Steelers Protocol, Joseph C. Maroon, M.D., Mark Lovell, Ph.D., Michael Collins, Ph.D., Jeff Bost PAC CNS 2002 Philadelphia

1. Maroon, J.C.: Endowed neuroscientist, Heindl Foundation and Mylan Laboratories

1. El-Kadi H, Kaufman H: Chronic Subdural Hematoma. Neurosurgery Clinics of North America. W.B. Saunders Company, Philadelphia, PA, July 2000.

1. Abla A, Oh M: Spinal chronic subdural hematoma. In: Chronic Subdural Hematoma. El-Kadi H, Kaufman HH (eds.), Neurosurgery Clinics of North America, W. B. Saunders Company, Philadelphia, PA, July 2000, pp. 465-471.

2. El-Kadi H.: Prognosis of chronic subdural hematoma. In: Chronic Subdural Hematoma. El-Kadi H, Kaufman HH (eds.), Neurosurgery Clinics of North America, W.B. Saunders Company, Philadelphia, PA, July 2000, pp. 553-567.

3. Kravtchouk AD, Likhterman LB, Potapov AA, El-Kadi H: Postoperative complications of chronic subdural hematomas: prevention and treatment. In: Chronic Subdural Hematoma. El-Kadi H, Kaufman HH (eds.), Neurosurgery Clinics of North America, W.B. Saunders Company, Philadelphia, PA, July 2000, pp. 547-552.

4. Dureza C, Tantuwaya LS and Maroon JC: Surgical approaches to the orbit. In: Cranial Base Surgery. Robertson, Robertson and Coakham (eds.), W.B. Saunders Company, Philadelphia, PA, November, 1999.

5. Wecht DA: Chronic subdural hematoma: a brief history. In: Chronic Subdural Hematoma. El-Kadi H, Kaufman HH (eds.), Neurosurgery Clinics of North America. W.B. Saunders Company, Philadelphia, PA, July 2000, pp. 395-398.

6. Kaynar MY, Wecht DA: Clinical spectrum and natural history of spinal vascular malformations. In: Spinal Vascular Malformations. Barrow D, Awad I (eds). American Association of Neurological Surgeons, 1999:45-55.

7. Wecht DA, Awad IA: Subarachnoid hemorrhage. In: Principles of Neurosurgery 2^nd Ed. Grossman RG and Loftus CM (eds). Lippincott-Raven, Philadelphia, PA, 1999:297-309.

1. Gross JD, Wecht DA, Alberstone CD, Lee R, Montgomery A, Tessman CL: Magnetic source imaging for cerebrovascular surgery. Journal of Neurosurgery Vol. 88 (1):187A.

1. Lovell MR, Iverson GL, Collins MW, McKeag D, Maroon JC: Does loss of consciousness predict neuropsychological decrements after concussion? Clin J Sports Med, (4): 193-198, October, 1999.

2. Maroon JC, Lovell MR, Norwig J, Podell K, Powell JW, Hartl R: Cerebral concussion in athletes: evaluation and neuropsychological testing. Neurosurg 47(3):659-672, September, 2000.

1. Maroon JC: Minimally invasive surgery of the spine. Hebrew University Medical School, Jerusalem. March, 2000.

1. Bost, J.: Failed back surgery syndrome. The American Association of Surgical Physician Assistants. San Francisco, CA, October, 1999.

2. Bost, J.: Spinal surgery overview and postoperative management. Neurologic Problems: Assessment and Management Workshop, UPMC-Passavant, Pittsburgh, PA, September 21, 2000.

3. Oh M, Lobaugh P, Bost J, Frantzen s, Abla A: Clinical and electrophysiologic correlation in cervical spondylotic myelopathy treated with surgery. The American Association of Neurological Surgeons 68th Annual Meeting, San Francisco, CA, April 8 – 13, 2000.

4. Maroon JC: Management of the injured athlete. ImPACT—a new neuropsychological tool for evaluating concussion in athletes. The American Association of Neurological Surgeons 68th Annual Meeting, San Francisco, CA, April 8 – 13, 2000.

5. Maroon JC: Minimally invasive surgery of the spine. The American Association of Neurological Surgeons 68th Annual Meeting, San Francisco, CA, April 8 – 13, 2000.

6. Maroon JC: Faith and healing. Calvary Baptist Church, Follansbee, WV, April 30, 2000.

7. Maroon JC: Faith and Healing. Cancer Caring Center, Pittsburgh, PA, May 17, 2000.

8. Maroon JC: Minimally invasive surgery of the spine. Eastern Ohio Chiropractic Society, Boardman, Ohio, Mary 24, 2000.

9. Maroon JC: Diagnosis and treatment of athletic concussions: A new approach. Samuel Francis School of Law Symposium, Sports Law Update 2000, University of Pittsburgh Law School, Pittsburgh, PA, June 13, 2000.

10. Maroon JC: Current concepts in minimally invasive discectomy: percutaneous, endoscopic, laser and microsurgical. First Interdisciplinary World Congress of Spinal Surgery. Berlin, Germany, August 27-September 1, 2000. (Organizing Committee)

11. Wecht DA: Interventional treatment of stroke: carotid endarterectomy. American Heart Associate Seminar, Pittsburgh, PA, October 2, 1999.

12. Wecht DA: Carotid artery disease and management. UPMC-St. Margaret Hospital Grand Rounds, Pittsburgh, PA, May 4, 2000.

13. Wecht DA: Carotid artery disease and management. UPMC-St. Margaret Hospital Grand Rounds, Pittsburgh, PA June 22, 2000.

1. Burke JP, Abla AA, Maroon JC, Field M, Bost J, Abla A and Abla A: Long-term outcome of lumbar pedicle screws. American Association of Neurological Surgeons Annual Meeting, Toronto, Ontario, April 2001.

2. Burke JP, Abla AA, Maroon JC, Field M, Bost J, Abla A and Abla A: Outcome comparison of Synthese cervical spine locking plate systems. American Association of Neurological Surgeons Annual Meeting, Toronto, Ontario, April 2001.

3. Burke JP, Abla AA, Maroon JC, Field M, Bost J, Abla A and Abla A: Radiographic and clinical outcomes using Pyramesh and Z-Plate instrumented fusion constructs for patients with thoracolumbar instability. American Association of Neurological Surgeons Annual Meeting, Toronto, Ontario, April 2001.

4. Burke JP, Abla AA, Maroon JC, Field M, Bost J, Abla A and Abla A: Posterior occipitocervical fusion in adults. American Association of Neurological Surgeons Annual Meeting, Toronto, Ontario, April 2001.

2000-2001 Summary Activity Report for Tri-State Neurosurgical Associates – UPMC

Physicians:

Joseph C. Maroon, MD – Clinical Professor and Vice Chairman, Department of Neurosurgery, Presbyterian University Hospital
Adnan A. Abla, MD – Clinical Associate Professor, Department of Neurosurgery, Presbyterian University Hospital
Matt El Kadi, MD, Ph.D. - Clinical Assistant Professor, Department of Neurosurgery, Presbyterian University Hospital
Daniel A. Wecht, MD - Clinical Assistant Professor, Department of Neurosurgery, Presbyterian University Hospital

Physician Assistants:

Jeff Bost PAC - Clinical Instructor, Department of Neurosurgery, Presbyterian University Hospital

Lawrence Marcello PAC - Department of Neurosurgery, Presbyterian University Hospital

Robin Lampenfeld PAC - Department of Neurosurgery, Presbyterian University Hospital

Erin Donovan PAC - Department of Neurosurgery, Presbyterian University Hospital

Hospital Affiliations:

UPMC Presbyterian University Hospital
UPMC Passavant Hospital
UPMC Shadyside Hospital
UPMC St. Margaret’s Hospital
UPMC McKeesport
Sewickley Hospital
Wheeling Hospital

Visiting Professor: Hebrew University Medical School, Jerusalem, March 12-17, 2000, Minimally Invasive Surgery of the Spine.

Books: Kennerdell, J.S.; Cockerham, K.P., Maroon, J.C., Rothfus, W.E.: Practice Diagnosis and Management of Orbital Disease. Butterworth-Heinemann, 2001.

Maroon, J.C., Lovell, M.R., Norwig, J., Podell, K., Powell, J.W., Hartl, R.: Cerebral concussion in athletes: Evaluation and neuropsychological testing. Neurosurg. 47(3):659-672, September, 2000.

Bejjani, G.K; Cockerham, K.P.; Kennerdell, J.S.; Maroon, J.C.: A reappraisal of surgery for orbital tumors. Part I: extraorbital approaches. Neurosurg Focus 10(5): Article 2, 1-6, 2001.

Bejjani, G.K.; Cockerham, K.P.; Kennerdell, J.S.; Maroon, J.S.: Surgery for orbital tumors. Part II: Transorbital approaches. Neurosurg Focus 10(5): Article 3, 1-6, 2001.

Maroon, J.C.: Management of the Injured Athlete. ImPACT--A New

Neuropsychological Tool for Evaluating Concussion in Athletes. American Association

of Neurological Surgeons 68th Annual Meeting, San Francisco, CA, April 8-13, 2000.

Maroon, J.C.: Faith and Healing. Calvary Baptist Church, Follansbee, WV, April 30, 2000.

Maroon, J.C.: Faith and Healing. Cancer Caring Center, Pittsburgh, PA, May17, 2000.

Maroon, J.C.: Current Concepts in Minimally Invasive Discectomy: Percutaneous, Endoscopic, Laser and Microsurgical. First Interdisciplinary World Congress of Spinal Surgery. Berlin, German, August 2 –September 1, 2000.

Maroon, J.C.: Cerebral Concussion in Athletes: Neuropsychological Evaluation and Testing. Congress of Neurological Surgeons Annual Meeting, San Antonio, TX, September, 2000.

Maroon, J.C.: Balance and a Surgical Career—an Oxymoron or Possibility. Clinical Congress of the American College of Surgeons, Chicago, IL, October 26, 2000.

Maroon, J.C.: Recent Advances in Brain Tumor Treatment. Ohio Cancer Research Annual Meeting, St. Clairsville, OH, March 30, 2001.

Maroon, J.C.: Overview of Minimally Invasive Techniques of Lumbar Discectomy: APLD, Chymopapain, Laser Discectomy, Microdiscectomy. American Association of Neurological Surgeons Annual Meeting, Toronto, Canada, April 21-26, 2001.

Maroon, J.C.: Sports Related Concussion: Evaluation and Neuropsychological Testing. American Association of Neurological Surgeons Annual Meeting, Toronto, Canada, April 21-26, 2001.

Read the article on Mike Alstott's Surgery by Dr. Maroon By KATHERINE SMITH, of the Tampa Trib, June 13, 2004

Sept 19, 2003, Press Release, Dr. Maroon to compete in Hawaii Ironman

RESEARCH:

Clinical Investigation of the Safety and Efficacy of Pulsed

Wheeling Hospital

BOOK CHAPTERS

ARTICLES

Clinical Research:

Matt El-Kadi, MD, Ph.D.

Clinical Research:

Presentations and Posters:

Book Chapter

Articles

Maroon, J.C.: Management of the Injured Athlete. ImPACT--A New